In order to assess the effectiveness and reliability of cytogenetic di
agnosis provided by fetal blood, we report the first 186 cases of feta
l blood sampling performed for rapid karyotype between 19-37 weeks of
pregnancy in our Prenatal Diagnosis Unit. The overall diagnostic succe
ss rate was 98%, achieving 100% in the last period of the study. Chrom
osomal anomalies were detected in 16% (29/182) of the fetuses. In malf
ormed fetuses this rate increased from 8-9% in isolated malformation o
r markers of aneuploidy to 50% in multiple malformations. In pregnanci
es in which a previous cytogenetic study in amniotic fluid was inconcl
usive, fetal blood made it possible to obtain a definitive result, wit
h no discrepancies found at phenotypic follow-up examination. Interest
ingly enough, one of the four previously defined as pseudomosaicisms w
as found to be a non-mosaic in fetal blood, and only 1 of 4 mosaicisms
was confirmed in fetal blood. In conclusion, cytogenetic analysis of
fetal blood samples appears to be effective, rapid and reliable to est
ablish the fetal karyotype in selected cases.